search
CAR-T cell therapy
Trends
- 1UConn Health Launches CAR-T Cell Therapy Program▼UConn Health Launches Cutting-Edge CAR-T Cell Therapy Program
UConn Health has announced the launch of a new CAR-T cell therapy program, a form of immunotherapy that engineers a patient's own immune cells to fight cancer. The initiative brings an advanced, personalised cancer treatment to the Connecticut institution, expanding access for patients in the region who previously had to travel elsewhere for such therapy.
- 2Anitocabtagene autoleucel shows sustained response in multiple myeloma▼Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
Anitocabtagene autoleucel, a cell therapy, is associated with sustained clinical responses in patients with heavily pretreated multiple myeloma, according to a report in medical news. The finding is notable for a disease where patients who have exhausted standard lines of treatment typically face poor outcomes. Clinicians are watching whether such CAR-T approaches can extend durable remissions.
- 3CAR-T Therapy Expands From Cancer to Autoimmune Diseases●Enhancing CAR-T Therapy: From Cancer to Autoimmune Diseases
Researchers at Yale School of Medicine are exploring how CAR-T cell therapy, originally developed to treat blood cancers, could be adapted to treat autoimmune diseases. The approach engineers a patient's immune cells to target disease-causing cells, and scientists are now studying its potential against conditions where the immune system attacks the body itself.